About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
A workplace of inclusion, equal opportunity and respect lives at the heart of Novartis culture and is an integral part of everything we do. It is key to driving innovation and business performance as ...
Stanowisko Sortuj rosnąco Biznes Położenie Witryna Data publikacji Territory Business Executive Regular (Sales), Full time Innovative Medicines India Telangana Lut 12, 2025 Territory Business ...
1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 47 of the Condensed Financial Report. Unless otherwise ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
(高级)医药代表 /(资深)产品专员 Redni sodelavec (prodaja), Full time Innovative Medicines China Xi an (Shaanxi Province) Feb 13, 2025 ...
1. Die Angaben in konstanten Wechselkursen (kWk), die Kernergebnisse und der Free Cashflow sind Nicht-IFRS-Kennzahlen. Erläuterungen der Nicht-IFRS-Kennzahlen finden sich auf Seite 47 der in ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results